Aridis pharmaceuticals announces first quarter 2021 results

Los gatos, calif., may 11, 2021 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported financial and corporate results for the first quarter ended march 31, 2021.
ARDS Ratings Summary
ARDS Quant Ranking